Titer & Impurity Testing
Minimizing cost during the production of biopharmaceutical drugs - while maintaining high standards of quality and safety - has created the need for technologies that can simplify the drug development workflow and reduce time-to-results.
From upstream processes such as cell line development to downstream processes like dynamic binding capacity assessment of purification columns, product contaminant testing and titer, the analytical capability of the Octet® BLI platform is enhancing efficiencies and maintaining quality during the development of biopharmaceutical drugs.
Boost your research and commercialization goals by combining BLI and SPR at an attractive promotional price.
Replace ELISA and HPLC with Octet® BLI assays for quantitation of antibodies and recombinant therapeutic proteins. Accurate and fast assays are easy to develop and transfer to quality control (QC) and manufacturing.
Read Application Note
HCPs often copurify with the drug product when expressed in bacterial, yeast or mammalian cell lines. HCPs in finished products can decrease the efficacy of the drug or cause adverse immunogenic reactions. Partnering with Cygnus Technologies, the Octet®Anti-CHO HCP Kit for quantitation of residual HCPs combines the Octet® BLI system's high throughput analysis with the broad HCP recognition and sensitivity of the Cygnus 3G antibody.
Read Technical Note
The Octet® RPA Kit enables simple, sensitive and accurate quantitation of leached Protein A in bioprocess samples. The kit utilizes a validated sample treatment method for dissociating Protein A from antibodies that does not require boiling, neutralization or centrifugation steps.
Download Datasheet
A comprehensive guide for designing and performing assays that accurately measure the binding kinetics of biomolecular interactions and analyte concen...
Using Octet® SAX Biosensors
For Process Development and Quality Control
Rapid, accurate and cost-effective quantitation of monoclonal antibodies (MAbs) is essential for bioprocessing.
Accelerating Antibody Discovery by Monitoring Titer and Glycosylation With the Octet® Platform
The cell line development group at Biogen IDEC needed a robust assay for the measurement of Fc-fusion protein in crude cell culture supernatants.
Generate high-quality kinetics and affinity data in a fraction of the time compared to standard multi-cycle kinetics using the Octet® SF3.
Monitors up to 96 biosensors simultaneously, enabling label-free detection for protein quantitation and kinetic characterization at unmatched speed
Ideal for high-throughput applications that demand high sensitivity and low sample volume requirements
Unmatched flexibility and versatility in protein analysis
Get the Latest Updates, Trends and Developments on Label-free, Stress-Free Solutions for Drug Discovery, Biologics Development and Biomanufacturing.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.